Skip NavigationSkip to Content
Return Return to Search Results

Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants

  1. Author:
    Das, K.
    Clark, A. D.
    Lewi, P. J.
    Heeres, J.
    de Jonge, M. R.
    Koymans, L. M. H.
    Vinkers, H. M.
    Daeyaert, F.
    Ludovici, D. W.
    Kukla, M. J.
    De Corte, B.
    Kavash, R. W.
    Ho, C. Y.
    Ye, H.
    Lichtenstein, M. A.
    Andries, K.
    Pauwels, R.
    de Bethune, M. P.
    Boyer, P. L.
    Clark, P.
    Hughes, S. H.
    Janssen, P. A. J.
    Arnold, E.

  2. Author Address

    Arnold, E, CABM, 679 Hoes Ln, Piscataway, NJ 08854 USA CABM, Piscataway, NJ 08854 USA. Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA. Janssen Pharmaceut, Ctr Mol Design, Vosselaar, Belgium. Janssen Res Fdn, B-2800 Mechelen, Belgium. NCI, HIV Drug Resistance Program, NIH, Ft Detrick, MD 21702 USA.
    1. Year: 2004
  2. Journal: Journal of Medicinal Chemistry
    1. 47
    2. 10
    3. Pages: 2550-2560
  4. Type of Article: Article
  1. Abstract:

    Anti-AIDS drug candidate and non-nucleoside reverse transcriptase inhibitor (NNRTI) TMC125-R165335 (etravirine) caused an initial drop in viral load similar to that observed with a five-drug combination in naive patients and retains potency in patients infected with NNRTI-resistant HIV-1 variants. TMC125-R165335 and related anti-AIDS drug candidates can bind the enzyme RT in multiple conformations and thereby escape the effects of drug-resistance mutations. Structural studies showed that this inhibitor and other diarylpyrimidine (DAPY) analogues can adapt to changes in the NNRTI-binding pocket in several ways: (1) DAPY analogues can bind in at least two conformationally distinct modes; (2) within a given binding mode, torsional flexibility ("wiggling") of DAPY analogues permits access to numerous conformational variants; and (3) the compact design of the DAPY analogues permits significant repositioning and reorientation (translation and rotation) within the pocket ("jiggling"). Such adaptations appear to be critical for potency against wild-type and a wide range of drug-resistant mutant HIV-1 RTs. Exploitation of favorable components of inhibitor conformational flexibility (such as torsional flexibility about strategically located chemical bonds) can be a powerful drug design concept, especially for designing drugs that will be effective against rapidly mutating targets

    See More

  1. Keywords:

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at FrederickClose Button

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel